Get started
Author

Parth Verma

Progression of index metastases in oligometastatic hormone-sensitive prostate cancer: implications for metastases directed therapy?
2025 · Parth Verma, Priyamvada Maitre, et al. · Prostate Cancer and Prostatic Diseases · 3
PDF
Vaginal Malignant Melanoma-Case Report and Comprehensive Review of Literature
2024 · Nimmya SK, Ajay Sasidharan, et al. · Indian Journal of Gynecologic Oncology · 1
Empty-RT: A Phase 2 Trial of Prostate Stereotactic Body Radiation Therapy With an Empty Bladder Approach
2026 · Vedang Murthy, Simran Gulati, et al. · International Journal of Radiation Oncology*Biology*Physics
33P Serum and urine long non-coding RNAs as potential non-invasive biomarkers for prostate cancer
2025 · P. Verma · ESMO Open
PDF
2084 PSMA PET response vs PSA nadir with ADT & ARPI in oligometastatic hormone sensitive prostate cancer
2025 · Parth Verma, Prachi Adole, et al. · Radiotherapy and Oncology
485 Safety of prostate SBRT treated with an empty bladder (EMPTY-RT): A prospective phase 2 trial.
2025 · Simran Gulati, Suman Ghosh, et al. · Radiotherapy and Oncology
Treatment Outcomes and Toxicity Profiles with PORTEC-3 Trial Regimen in South Asian Cohort of High-Risk Endometrial Cancer Patients: A Single-Center Ambispective Analysis
2024 · Parth Verma, Rajasree Rajan, et al. · South Asian Journal of Cancer
PDF
27P Treatment outcomes and toxicity profiles in South Asian patients of high-risk endometrial cancer treated with PORTEC-3 trial regimen
2023 · P. Verma, A. Sasidharan, et al. · ESMO Open
PDF
Abnormal olfactory perception during stereotactic radiation therapy using Cyberknife for primary brain tumor: A case study.
2022 · Parth Verma, Sruthi K Reddy, et al. · PubMed
Works count: 10
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type